Pharmacological interventions for social cognitive impairments in schizophrenia: A protocol for a systematic review and network meta-analysis

BackgroundSocial cognitive impairments adversely affect social functioning (e.g., employment status) in patients with schizophrenia. Although pharmacological interventions have been suggested to provide some benefits on social cognition, little information is available on the comparative efficacy of...

Full description

Saved in:
Bibliographic Details
Published in:Frontiers in psychology 2022-08, Vol.13, p.878829-878829
Main Authors: Yamada, Yuji, Okubo, Ryo, Tachimori, Hisateru, Uchino, Takashi, Kubota, Ryotaro, Okano, Hiroki, Ishikawa, Shuhei, Horinouchi, Toru, Takanobu, Keisuke, Sawagashira, Ryo, Hasegawa, Yumi, Sasaki, Yohei, Nishiuchi, Motohiro, Kawashima, Takahiro, Tomo, Yui, Hashimoto, Naoki, Ikezawa, Satoru, Nemoto, Takahiro, Watanabe, Norio, Sumiyoshi, Tomiki
Format: Article
Language:English
Subjects:
network meta-analysis
pharmacotherapy
Psychology
schizophrenia
social cognition
systematic review
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:BackgroundSocial cognitive impairments adversely affect social functioning (e.g., employment status) in patients with schizophrenia. Although pharmacological interventions have been suggested to provide some benefits on social cognition, little information is available on the comparative efficacy of pharmacotherapy. Thus, the aim of this planned systematic review and network meta-analysis is to perform a quantitative comparison of the effects of various psychotropic drugs, including supplements, on social cognition disturbances of schizophrenia. MethodsThe literature search will be carried out using the PubMed, Embase, Cochrane Central Register of Controlled Trials, PsycINFO, ClinicalTrials.gov, and International Clinical Trials Registry Platform databases from inception onward. Randomized controlled trials that examined the efficacy of drugs in social cognitive disturbances will be included, based on the most recent studies and the broader literature than previously searched. This protocol defines a priori the methods that will be used for study selection, data collection, quality assessment, and statistical syntheses. DiscussionThe findings this work are expected to help promote the development of better therapeutics of social cognitive impairments in schizophrenia and related psychiatric conditions. Systematic Review Registration[www.crd.york.ac.uk/prospero], identifier [CRD42021293224].
ISSN:1664-1078
1664-1078
DOI:10.3389/fpsyg.2022.878829